Sanofi : FDA to review isatuximab as a potential treatment for relapsed/refractory multiple myeloma

NEXT STORY
Philips and Centre Hospitalier Régional Universitaire de Nancy announce 10-year enterprise informatics agreement to increase efficiency and improve patient care
PREV STORY
ABOG Appoints New Board of Directors Members, Division Chair, and Members of Subspecialty Divisions
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Loxo Oncology to Announce Fourth Quarter and Year-End 2016 Financial Results

STAMFORD, Conn., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical ...

author_avatar
NASDAQ Market News

ABLYNX ANNOUNCES WARRANT EXERCISE

REGULATED INFORMATION GHENT, Belgium, 18 January 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] ...

author_avatar
NASDAQ Market News

WakeMed Health & Hospitals Selects Lexmark Accounts Payable Automation

LEXINGTON, Ky., Oct. 8, 2015 (GLOBE NEWSWIRE) -- News Facts Lexmark announces that Raleigh, ...

author_avatar
NASDAQ Market News